Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1985 2
1986 4
1987 11
1988 23
1989 29
1990 44
1991 57
1992 84
1993 108
1994 136
1995 159
1996 165
1997 196
1998 221
1999 208
2000 278
2001 246
2002 300
2003 282
2004 321
2005 338
2006 358
2007 375
2008 336
2009 352
2010 310
2011 323
2012 358
2013 331
2014 337
2015 319
2016 291
2017 296
2018 265
2019 277
2020 304
2021 291
2022 302
2023 272
2024 243
2025 270
2026 152

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

8,668 results

Results by year

Filters applied: . Clear all
Page 1
Update on RYR1-related myopathies.
Ogasawara M, Nishino I. Ogasawara M, et al. Curr Opin Neurol. 2024 Oct 1;37(5):504-508. doi: 10.1097/WCO.0000000000001296. Epub 2024 Jul 12. Curr Opin Neurol. 2024. PMID: 38994695 Review.
PURPOSE OF REVIEW: RYR1-related myopathy (RYR1-RM) is a group of myopathies caused by mutations in the RYR1 gene, which encodes the ryanodine receptor 1 (RYR1). ...However, recent clinical trials of Rycal ARM210 in patients with RYR1 …
PURPOSE OF REVIEW: RYR1-related myopathy (RYR1-RM) is a group of myopathies caused by mutations in the RYR1 gene, which …
Intracellular calcium leak as a therapeutic target for RYR1-related myopathies.
Kushnir A, Todd JJ, Witherspoon JW, Yuan Q, Reiken S, Lin H, Munce RH, Wajsberg B, Melville Z, Clarke OB, Wedderburn-Pugh K, Wronska A, Razaqyar MS, Chrismer IC, Shelton MO, Mankodi A, Grunseich C, Tarnopolsky MA, Tanji K, Hirano M, Riazi S, Kraeva N, Voermans NC, Gruber A, Allen C, Meilleur KG, Marks AR. Kushnir A, et al. Acta Neuropathol. 2020 Jun;139(6):1089-1104. doi: 10.1007/s00401-020-02150-w. Epub 2020 Mar 31. Acta Neuropathol. 2020. PMID: 32236737 Free PMC article.
RYR1 encodes the type 1 ryanodine receptor, an intracellular calcium release channel (RyR1) on the skeletal muscle sarcoplasmic reticulum (SR). Pathogenic RYR1 variations can destabilize RyR1 leading to calcium …
RYR1 encodes the type 1 ryanodine receptor, an intracellular calcium release channel (RyR1) …
Therapies for RYR1-Related Myopathies: Where We Stand and the Perspectives.
Beaufils M, Travard L, Rendu J, Marty I. Beaufils M, et al. Curr Pharm Des. 2022;28(1):15-25. doi: 10.2174/1389201022666210910102516. Curr Pharm Des. 2022. PMID: 34514983 Review.
RyR1-related myopathies are a family of genetic neuromuscular diseases due to mutations in the RYR1 gene. ...We review the most recent results obtained for the treatment of RyR1-related myopathies, and, in view of the progress in therapeutic development for o …
RyR1-related myopathies are a family of genetic neuromuscular diseases due to mutations in the RYR1 gene. ...We review the mos …
'Dusty core disease' (DuCD): expanding morphological spectrum of RYR1 recessive myopathies.
Garibaldi M, Rendu J, Brocard J, Lacene E, Fauré J, Brochier G, Beuvin M, Labasse C, Madelaine A, Malfatti E, Bevilacqua JA, Lubieniecki F, Monges S, Taratuto AL, Laporte J, Marty I, Antonini G, Romero NB. Garibaldi M, et al. Acta Neuropathol Commun. 2019 Jan 5;7(1):3. doi: 10.1186/s40478-018-0655-5. Acta Neuropathol Commun. 2019. PMID: 30611313 Free PMC article.
Several morphological phenotypes have been associated to RYR1-recessive myopathies. We recharacterized the RYR1-recessive morphological spectrum by a large monocentric study performed on 54 muscle biopsies from a large cohort of 48 genetically confirmed patients, us …
Several morphological phenotypes have been associated to RYR1-recessive myopathies. We recharacterized the RYR1-recessive morp …
Gene therapies for RyR1-related myopathies.
Marty I, Beaufils M, Fauré J, Rendu J. Marty I, et al. Curr Opin Pharmacol. 2023 Feb;68:102330. doi: 10.1016/j.coph.2022.102330. Epub 2022 Dec 16. Curr Opin Pharmacol. 2023. PMID: 36529094 Review.
Myopathies related to variations in the RYR1 gene are genetic diseases for which the therapeutic options are sparse, in part because of the very large size of the gene and protein, and of the distribution of variations all along the sequence. ...
Myopathies related to variations in the RYR1 gene are genetic diseases for which the therapeutic options are sparse, in part because …
Variant curation expert panel recommendations for RYR1 pathogenicity classifications in malignant hyperthermia susceptibility.
Johnston JJ, Dirksen RT, Girard T, Gonsalves SG, Hopkins PM, Riazi S, Saddic LA, Sambuughin N, Saxena R, Stowell K, Weber J, Rosenberg H, Biesecker LG. Johnston JJ, et al. Genet Med. 2021 Jul;23(7):1288-1295. doi: 10.1038/s41436-021-01125-w. Epub 2021 Mar 25. Genet Med. 2021. PMID: 33767344 Free PMC article.
RESULTS: Seven ACMG/AMP criteria were adopted without changes, nine were adopted with RYR1-specific modifications, and ten were dropped. The in silico (PP3 and BP4) and hotspot criteria (PM1) were evaluated quantitatively. ...CONCLUSION: Curation of these variants will fac …
RESULTS: Seven ACMG/AMP criteria were adopted without changes, nine were adopted with RYR1-specific modifications, and ten were dropp …
RYR1-Related Rhabdomyolysis: A Spectrum of Hypermetabolic States Due to Ryanodine Receptor Dysfunction.
Kruijt N, den Bersselaar LV, Snoeck M, Kramers K, Riazi S, Bongers C, Treves S, Jungbluth H, Voermans N. Kruijt N, et al. Curr Pharm Des. 2022;28(1):2-14. doi: 10.2174/1381612827666210804095300. Curr Pharm Des. 2022. PMID: 34348614 Review.
Variants in the ryanodine receptor-1 gene (RYR1) have been associated with a wide range of neuromuscular conditions, including various congenital myopathies and malignant hyperthermia (MH). ...For the treatment or prevention of RYR1-related rhabdomyoly …
Variants in the ryanodine receptor-1 gene (RYR1) have been associated with a wide range of neuromuscular conditions, in …
Expanding the clinical-pathological and genetic spectrum of RYR1-related congenital myopathies with cores and minicores: an Italian population study.
Fusto A, Cassandrini D, Fiorillo C, Codemo V, Astrea G, D'Amico A, Maggi L, Magri F, Pane M, Tasca G, Sabbatini D, Bello L, Battini R, Bernasconi P, Fattori F, Bertini ES, Comi G, Messina S, Mongini T, Moroni I, Panicucci C, Berardinelli A, Donati A, Nigro V, Pini A, Giannotta M, Dosi C, Ricci E, Mercuri E, Minervini G, Tosatto S, Santorelli F, Bruno C, Pegoraro E. Fusto A, et al. Acta Neuropathol Commun. 2022 Apr 15;10(1):54. doi: 10.1186/s40478-022-01357-0. Acta Neuropathol Commun. 2022. PMID: 35428369 Free PMC article.
Mutations in the RYR1 gene, encoding ryanodine receptor 1 (RyR1), are a well-known cause of Central Core Disease (CCD) and Multi-minicore Disease (MmD). ...In addition, this study highlighted the structural bioinformatics potential in the prediction of …
Mutations in the RYR1 gene, encoding ryanodine receptor 1 (RyR1), are a well-known cause of Central Core Disease …
Treatments for RYR1-related disorders.
Raga S, Voermans N, Perez-Neri I, Dowling J, Jungbluth H, Baranello G, Servais L, Tillema A, Wilmshurst J. Raga S, et al. Cochrane Database Syst Rev. 2024 Dec 10;12(12):CD014439. doi: 10.1002/14651858.CD014439. Cochrane Database Syst Rev. 2024. PMID: 39655671 Free PMC article.
The objectives are as follows: Primary objective To analyse the benefits and harms of pharmacological or other interventions (e.g. special diet, exercise programme) compared with placebo or standard care for RYR1-related disorders, including both permanent myopathies and i …
The objectives are as follows: Primary objective To analyse the benefits and harms of pharmacological or other interventions (e.g. special d …
Challenges in genetic counseling for RYR1-related myopathies.
Shimomura R, Kihara Y, Yanagishita T, Ishiguro K, Shichiji M, Sato T, Shimojima Yamamoto K, Ishihara Y, Nagata M, Miyashita Y, Asano Y, Ishigaki K, Nagata S, Yamamoto T. Shimomura R, et al. Brain Dev. 2025 Jun;47(3):104363. doi: 10.1016/j.braindev.2025.104363. Epub 2025 Apr 30. Brain Dev. 2025. PMID: 40311547 Review.
BACKGROUND: Ryanodine receptor 1 (RYR1)-related myopathy is inherited in an autosomal dominant (AD) or recessive (AR) manner. ...METHODS: In this study, PubMed was used to perform literature review on genetic counseling for RYR1-related myopathy. RESUL …
BACKGROUND: Ryanodine receptor 1 (RYR1)-related myopathy is inherited in an autosomal dominant (AD) or recessive (AR) m …
8,668 results